It is our pleasure to inform you that the 16th Ataxia-Telangiectasia Workshop (ATW) will be held in Beijing, China, on Oct. 11-14th, 2015. The host is the Beijing Key Laboratory of DNA Damage Response, Capital Normal University (CNU). The co-organizers are Drs. Zhao-Qi Wang (Leibniz Institute of Age Research-Fritz Lipmann Institute (FLI), Germany) and Xingzhi (Xavier) Xu (CNU).
The ATW has been held since 1980 every 2-3 years. The meeting series is unique in that it focuses comprehensively on the various facets of the A-T disease. The meetings have been located in different parts of the world and organized by volunteers from those locations. This serves to recognize their leadership in AT/ATM research and allows local young investigators to attend and participate, who might otherwise not have that opportunity. This year’s meeting is the 16th of the series.
The ATW traditionally gathers basic research scientists, clinicians and social helpers to discuss the progress and current status of the A-T research, aiming to deliver strategies to cure the disease. The scientific presentations and discussions will strengthen basic and clinical research and promote the exchange of information among scientists and clinicians, all of which the A-T patients and / or individual suffering from A-T-related diseases will benefit. The extensive research on the molecular and genetic mechanisms behind the A-T diseases has focused on the gene mutated in A-T, i.e., ATM. In recent years the identification and characterization of ATM partners and substrates have greatly advanced our understanding on the manifestation of the disease and on the development of possible therapeutic strategies. With support of the well-established scientists in the field, we believe that we have assembled a very attractive and state-of-the-art scientific program.
China has recently dramatically increased its scientific contribution to a global landscape of biomedical research, including studies in the DNA damage response, neurobiology and cancer biology, which are major aspects of A-T. Although China is not a highly prevalent country of A-T (this can also be due to limited available information), the ATW2015-Beijing will bring the attention of the Chinese researchers to the A-T disease and its related research. The meeting will cover molecular and cellular studies of ATM and its interacting networks in DNA damage related or non-related signaling and the clinical aspects of the disease.
On behalf of the organizers and the Scientific Committee, we would like to invite you to register for and submit an abstract to ATW2015-Beijing. Please be informed that up to 10 submitted abstracts will be selected for oral presentations, up to 10 travel awards (each worth US$500) will be given away, and up to 6 poster awards (each worth US$300) will be identified. More importantly, all these awards will be selected exclusively by the science quality of your abstract/presentation. We are confident that your participation will strengthen the discussion, promote basic and clinical research, and benefit the cure of the AT and AT-related diseases.
We are looking forward to your participation.
Xingzhi (Xavier) Xu & Zhao-Qi Wang
Co-organizers of ATW2015-Beijing